AptarGroup, Inc. 10-Q Summary: Quarter Ended June 30, 2001
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2001, and the six-month period ended on that date. AptarGroup, Inc. is a global manufacturer of dispensing systems for the pharmaceutical, fragrance/cosmetic, personal care, and food/beverage markets. The company operates significant facilities outside the United States, creating exposure to foreign currency fluctuations.
Key Financial Metrics
| Metric | Q2 2001 | Q2 2000 | 6M 2001 | 6M 2000 |
|---|---|---|---|---|
| Net Sales ($ millions) | $231.8 | $227.7 | $464.7 | $445.3 |
| Operating Income ($ millions) | $25.6 | $31.2 | $56.9 | $59.8 |
| Net Income ($ millions) | $15.2 | $17.8 | $33.3 | $34.1 |
| Diluted EPS ($) | $0.41 | $0.49 | $0.91 | $0.93 |
| Operating Margin (%) | 11.1% | 13.7% | 12.2% | 13.4% |
| Cash from Operations ($ millions) | N/A | N/A | $46.6 | $53.2 |
| Cash and Equivalents ($ millions) | $40.4 | N/A | $40.4 | $36.9 |
| Net Debt to Capitalization (%) | 35% | N/A | 35% | 35% |
Note: Q2 cash flow data is not explicitly broken out in the summary tables; six-month figures are provided.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2% in Q2 and 4% for the six months ended June 30, 2001, compared to the prior year. However, "Core Sales" (excluding currency impacts) grew 6% in Q2 and 9% for the six-month period, indicating underlying business strength offset by a stronger U.S. dollar.
- Profitability Decline: Operating income decreased $5.5 million in Q2 and $2.9 million for the six months. This decline is primarily driven by a one-time "Strategic Initiative" charge of $7.3 million (excluding $0.5 million in accelerated depreciation) related to plant closures and asset impairments.
- Excluding Special Items: Management notes that excluding Strategic Initiative charges and accelerated depreciation, operating income would have increased 7% in Q2 and nearly $4.9 million for the six-month period.
- Cash Flow: Net cash provided by operations decreased to $46.6 million for the six months ended June 30, 2001, from $53.2 million in the prior year, largely due to changes in income taxes payable and deferred taxes.
Guidance, Outlook, and Risks
- Strategic Initiative: The company is restructuring operations to improve efficiency in mass-market fragrance/cosmetic and personal care pump production. This involves closing a U.S. molding operation and consolidating production in Italy. Total charges are expected to be approximately $10 million, with an additional $2.3 million expected in future periods (mostly non-cash accelerated depreciation and stay bonuses).
- Cost Savings: The initiative is expected to yield annual savings exceeding $5 million upon completion in Q4 2002, driven by a net global personnel reduction of approximately 90 employees.
- Earnings Guidance: The company reaffirms full-year 2001 EPS guidance of $1.95 to $2.05, excluding Strategic Initiative charges. Q3 2001 EPS is anticipated to be $0.48 to $0.52, also excluding these charges.
- Market Risks: Significant exposure to foreign currency exchange rates (Euro, Yen, Pound) impacts translation of results. A strengthening U.S. dollar has a dilutive effect. The company also faces risks related to raw material costs, customer spending levels, and the successful execution of the Strategic Initiative.
- Accounting Changes: The company adopted SFAS No. 133 regarding derivative instruments, resulting in a cumulative effect adjustment of $(64,000) to net income. The company plans to adopt SFAS No. 142 (Goodwill) in 2002, which will stop goodwill amortization.
Investor Verification Checklist
- Strategic Initiative Execution: Verify the timeline for the plant closure in Connecticut and the consolidation in Italy, and monitor the realization of the projected $5 million in annual savings.
- Currency Impact: Assess the sensitivity of future earnings to U.S. dollar strength, given that over 60% of sales are generated outside the U.S.
- Asset Impairment Validity: Review the assumptions used to calculate the $5.5 million asset impairment charge regarding non-modular pumps.
- Capital Expenditures: Confirm that capital spending remains within the projected $85 to $90 million range for the full year 2001.
- Debt Structure: Monitor the utilization of the $100 million revolving credit facility and the company's ability to refinance short-term obligations.